Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.42 USD
Change Today +0.44 / 4.90%
Volume 245.9K
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

lemaitre vascular inc (LMAT) Snapshot

Open
$9.29
Previous Close
$8.98
Day High
$9.45
Day Low
$9.00
52 Week High
05/4/15 - $9.45
52 Week Low
10/16/14 - $6.48
Market Cap
164.9M
Average Volume 10 Days
66.1K
EPS TTM
$0.33
Shares Outstanding
17.5M
EX-Date
05/20/15
P/E TM
28.4x
Dividend
$0.16
Dividend Yield
1.54%
Current Stock Chart for LEMAITRE VASCULAR INC (LMAT)

Related News

No related news articles were found.

lemaitre vascular inc (LMAT) Related Businessweek News

No Related Businessweek News Found

lemaitre vascular inc (LMAT) Details

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable less invasive removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin and provides interventionists to cross-reference between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. Further, it offers valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches used in conjunction with carotid endarterectomy, remote endarterectomy, and other vascular reconstructions; vessel closure systems that allows surgeons to attach vessels to one another by deploying titanium clips in place of suturing; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, as well as distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

325 Employees
Last Reported Date: 03/18/15
Founded in 1983

lemaitre vascular inc (LMAT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $320.6K
President and Director
Total Annual Compensation: $353.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $247.2K
President of International Operations
Total Annual Compensation: $295.1K
Compensation as of Fiscal Year 2014.

lemaitre vascular inc (LMAT) Key Developments

Lemaitre Vascular, Inc. Approves Quarterly Dividend, Payable on June 5, 2015

On April 23, 2015, the LeMaitre Vascular, Inc.'s board of directors approved a quarterly dividend of $0.04 per share of common stock. The dividend will be paid June 5, 2015 to shareholders of record on May 22, 2015.

Lemaitre Vascular, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Second Quarter of 2015 and Fiscal 2015

LeMaitre Vascular, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. The company reported net sales of $18,947,000, income from operations of $2,309,000, income before income taxes of $2,326,000, net income of $1,369,000 or $0.08 per diluted share against net sales of $16,754,000, loss from operations of $231,000, loss before income taxes of $273,000, net loss of $207,000 or $0.01 per diluted share a year ago. EBITDA was $3,158,000 against $558,000 a year ago. The Company expects second quarter 2015 sales of $18.9 million, a reported increase of 4% vs. second quarter 2014. Excluding currency effects, this represents 12% sales growth. Excluding currency effects and acquisitions, this represents 6% sales growth (organic growth). The company expects second quarter 2015 gross margin of 69.5%. The company also expects second quarter 2015 operating income of $2.0 million (11% operating margin). The company has increased its full-year 2015 sales guidance to $75.0 million, a reported increase of 5% vs. 2014. Excluding currency effects, this represents 13% sales growth. Excluding currency effects and acquisitions, this represents 8% sales growth (organic growth). The company expects 2015 gross margin of 69.5%. The company has increased its 2015 operating income guidance to $8.2 million (11% operating margin), an increase of 30% vs. 2014.

LeMaitre Vascular, Inc. to Report Q1, 2015 Results on Apr 28, 2015

LeMaitre Vascular, Inc. announced that they will report Q1, 2015 results at 5:00 PM, Eastern Daylight on Apr 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMAT:US $9.42 USD +0.44

LMAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $22.85 USD +0.60
CryoLife Inc $10.18 USD +0.09
Hansen Medical Inc $0.89 USD +0.04
Stereotaxis Inc $1.97 USD +0.0599
Vascular Solutions Inc $32.50 USD -0.13
View Industry Companies
 

Industry Analysis

LMAT

Industry Average

Valuation LMAT Industry Range
Price/Earnings 28.7x
Price/Sales 2.2x
Price/Book 2.3x
Price/Cash Flow 28.6x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEMAITRE VASCULAR INC, please visit www.lemaitre.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.